lysine has been researched along with Fatty Liver, Nonalcoholic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 7 (53.85) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, RJ; Hu, MJ; Long, M | 1 |
| Jung, DY; Jung, MH; Kim, JH; Nagappan, A; Suh, N | 1 |
| Cook, SA; Diehl, AM; Ho, JP; Pang, J; Petretto, E; Shekeran, SG; Singh, BK; Suzuki, A; Tripathi, M; Widjaja, AA; Yen, PM; Zhou, J | 1 |
| Gordts, PLSM; Harrington, AR; Nora, C; Omar, I; Pollow, DP; Ramms, B; Sander, M; Wortham, M; Zhu, H | 1 |
| Cao, X; Dong, Y; Fan, Y; Hou, J; Jia, K; Li, N; Li, Y; Li, Z; Lu, S; Wang, M; Wang, S; Yang, Y; Yu, Y; Zhang, D; Zhang, L; Zhang, W; Zhou, Y | 1 |
| Cai, M; Cai, Q; Cao, H; Chen, S; Guan, H; Guo, W; Liang, H; Qin, H; Su, Q; Wang, T; Xian, Y; Xu, F; Zeng, L | 1 |
| Aghayev, M; Arias-Alvarado, A; Ilchenko, S; Kasumov, T; Lepp, J; Previs, S; Rachdaoui, N; Tsai, TH; Zhang, GF | 1 |
| Beland, FA; de Conti, A; Dreval, K; Orisakwe, OE; Pogribny, IP; Ross, SA; Tryndyak, V | 1 |
| Ito, Y; Muramatsu, N; Nagasawa, T; Sato, T; Yamamoto, Y | 1 |
| Cui, J; He, FL; Hu, G; Lin, YJ; Ren, XH; Shen, T; Wei, J; Zhen, YZ | 1 |
| Chang, XX; Dou, X; Gao, X; Ge, X; Guo, L; Huang, HY; Lei, QY; Li, X; Liu, Y; Qian, SW; Tang, QQ; Wei, XB; Zhou, SR | 1 |
| Buch, A; Erez, N; Halpern, Z; Kolodkin-Gal, I; Salomone, F; Shibolet, O; Webb, M; Yeshua, H; Zelber-Sagi, S | 1 |
| Bloemen, JG; Buurman, WA; Dejong, CH; Driessen, A; Gaens, KH; Greve, JW; Hofker, MH; Niessen, PM; Rensen, SS; Schalkwijk, CG; Stehouwer, CD; Wolfs, MG | 1 |
13 other study(ies) available for lysine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.
Topics: Acetylation; Case-Control Studies; Fatty Acids; Gene Expression Regulation; Hep G2 Cells; Histones; Humans; Lipid Metabolism; Liver; Lysine; MicroRNAs; Non-alcoholic Fatty Liver Disease; Receptors, AMPA; RNA, Long Noncoding | 2022 |
Histone Demethylase KDM7A Contributes to the Development of Hepatic Steatosis by Targeting Diacylglycerol Acyltransferase 2.
Topics: Animals; Diacylglycerol O-Acyltransferase; Hep G2 Cells; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Promoter Regions, Genetic; Triglycerides | 2021 |
Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression.
Topics: Animals; Fatty Acids; Lysine; Mice; Mitochondria; Non-alcoholic Fatty Liver Disease; Peptide Initiation Factors; Spermidine | 2022 |
Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in Obesity.
Topics: Animals; Diabetes Mellitus, Type 2; Histone Demethylases; Inflammation; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Liver; Lysine; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity | 2022 |
JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cholesterol; Humans; Interleukin-6; Liver Neoplasms; Lysine; Mice; Mice, Knockout; Non-alcoholic Fatty Liver Disease | 2022 |
Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD.
Topics: Acetyl-CoA Carboxylase; Diet, Ketogenic; Humans; Liver; Lysine; Non-alcoholic Fatty Liver Disease; Protein Processing, Post-Translational | 2023 |
Measuring acetyl-CoA and acetylated histone turnover in vivo: Effect of a high fat diet.
Topics: Acetyl Coenzyme A; Acetylation; Animals; Deuterium Oxide; Diet, High-Fat; Histones; Humans; Liver; Lysine; Male; Mass Spectrometry; Mice; Non-alcoholic Fatty Liver Disease; Protein Processing, Post-Translational | 2021 |
Inhibition of the Cell Death Pathway in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocarcinogenesis Is Associated with Histone H4 lysine 16 Deacetylation.
Topics: Acetylation; Animals; Carcinoma, Hepatocellular; Cell Death; Disease Models, Animal; Histones; Humans; Liver Neoplasms; Lysine; Mice; Non-alcoholic Fatty Liver Disease | 2017 |
L-Lysine Attenuates Hepatic Steatosis in Senescence-Accelerated Mouse Prone 8 Mice.
Topics: Aging; Alanine Transaminase; Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Cholesterol; Diet; Dietary Supplements; Disease Models, Animal; Liver; Lysine; Male; Metabolic Syndrome; Mice; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Proto-Oncogene Proteins c-akt; Risk Factors; RNA, Messenger; Triglycerides | 2018 |
Rhein lysinate decreases inflammation and adipose infiltration in KK/HlJ diabetic mice with non-alcoholic fatty liver disease.
Topics: Adipose Tissue; Animals; Anthraquinones; Diabetes Mellitus, Experimental; Inflammation; Inflammation Mediators; Lysine; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2016 |
Acetylation of Mitochondrial Trifunctional Protein α-Subunit Enhances Its Stability To Promote Fatty Acid Oxidation and Is Decreased in Nonalcoholic Fatty Liver Disease.
Topics: Acetylation; Animals; Disease Models, Animal; Fatty Acids; HEK293 Cells; Humans; Lipid Metabolism; Lysine; Mice; Mitochondrial Proteins; Mitochondrial Trifunctional Protein, alpha Subunit; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Protein Stability; Sirtuins; Ubiquitination | 2016 |
Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease.
Topics: Adult; Biomarkers; Case-Control Studies; Female; Humans; Israel; Life Style; Logistic Models; Lysine; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Receptor for Advanced Glycation End Products; Solubility; Surveys and Questionnaires | 2017 |
Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis.
Topics: Aged; Biomarkers; Biopsy; Cytokines; Enzyme Inhibitors; Fatty Liver; Female; Gene Expression; Guanidines; Hep G2 Cells; Hepatocytes; Humans; In Vitro Techniques; Liver; Lysine; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Pyridoxamine; Vitamin B Complex | 2012 |